Keep up to date with the latest developments from CERSI-PGx, including news articles, research publications, workshops, and events. This page provides timely information for researchers, industry professionals, regulators, and the public interested in pharmacogenomics.
- Latest Publications
- Upcoming Events
- Past Events Archive
LinkedIn Feed
News & Events
-
New CERSI-PGx Clinical Guidelines: Universal CYP2C19 Genotyping for Clopidogrel Prescribing
CERSI-PGx has published comprehensive UK clinical guidelines recommending universal CYP2C19 genotype testing for patients prescribed clopidogrel. Covering stroke, coronary artery disease, and peripheral arterial disease,… read article →
-
UK Launches CERSI-PGx to Revolutionise Pharmacogenomics and Patient Safety
The UK has officially launched the Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) to accelerate the adoption of personalized medicine. Led… read article →
-
Free eLearning Portal Launched to Empower Healthcare Professionals with Genomic Literacy
The Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) has launched a new, free eLearning portal to bridge the gap between genomic… read article →
-
CERSI-PGx Launches New eLearning Portal to Support Clinical Pharmacogenomics
We are pleased to share the official launch of the CERSI-PGx eLearning Portal → Developed by the Centre of Excellence in Regulatory Science and Innovation… read article →
-
CERSI-PGx Workshop: Showcasing Outcomes and Shaping the Future of Pharmacogenomics
We are delighted to invite stakeholders, industry partners, and healthcare professionals to the CERSI-PGx Workshop: Outcomes and Next Steps. Taking place on 20–21 January 2026… read article →
-
University of Liverpool to Lead New National Centre for Pharmacogenomics Innovation
The University of Liverpool has officially been named the lead institution for the new Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).… read article →
Learn more about each work package →
- WP1 – Developing UK-Based Guidelines
- WP2 – Pathway for Industry Pharmacogenomic Testing
- WP3 – Education and Training
- WP4 – Health Economics of PGx
- WP5 – Patient and Public Engagement